Mallinckrodt Plc - New Common Stock

As of the most recent data (March 2026), MNK shows a common stock of $400K. That compares with $-1.7M in the prior-year period — up 123.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, MNK's common stock is now $400K (was $-1.7M) — a 123.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Mallinckrodt Plc - New is outperforming or lagging.

Tracking MNK's common stock over time shows whether Mallinckrodt Plc - New is scaling, shrinking, or reshaping that part of the business. The current reading is $400K That compares with $-1.7M in the prior-year period — up 123.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this common stock page, Stockcircle has Mallinckrodt Plc - New's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $400K) with ownership activity and broader fundamentals.

Mallinckrodt Plc - New's common stock is $400K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.